Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Successful use of artificial intelligence and machine learning (AI/ML) to add value in clinical data management demands a clear data strategy. Having a robust data flow, delivering faster, better and more cost-effectively, enabling data to be used as a fuel to drive clinical development.
IQVIA's combination of a digitized process, centralized data, and standards. A clear data strategy is key to a distinctive data flow that helps deliver faster, better and more cost-effectively – using data as a fuel to advance clinical development. Integrating AI/ML capabilities to provide intelligent automation results in higher quality and more efficient digitized processes. Intelligent automation can be used to drive productivity in study start-up activities such as EDC design & build based on a connected ecosystem, with a sound approach to risk mitigation taking into account data-, model-, and knowledge-related factors. All these advances can support life science industry efforts to optimize data management to further improve patient health and safety.
Download our Insight brief to find out more.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Decrease clinical development costs and increase study quality using our global functional resources and flexible services, and get more value from your R&D spend.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Improve the performance of your clinical trials with the power of the IQVIA CORE.
Ensure you have access to insights early with connected devices and clean, analysis-ready data